Merrimack Pharmaceuticals and sanofi-aventis Initiate Enrollment in a Phase 2 Combination Study of MM-121 and …

Published July 22, 2010

Merrimack Pharmaceuticals and sanofi-aventis Initiate Enrollment in a Phase 2 Combination Study of MM-121 and …
The trial, enrolling patients at multiple centers across the United States, is part of a broad Phase 2 program for MM-121 launched by Merrimack and sanofi-aventis this year
Read more on PRWeb via Yahoo! News

Police close case on missing Waynesboro woman
Dannell Kraus death case closed, but mystery remains.
Read more on The News Virginian

Snapshot: Partnership Goals, Track Records in the RNAi/miRNA Space
Rosetta Genomics President and CEO Kenneth Berlin this week told investors that the microRNA diagnostics shop expects to form at least one strategic partnership before the end of the year.
Read more on GenomeWeb News